Y
Yohannes T. Ghebre
Researcher at Baylor College of Medicine
Publications - 23
Citations - 727
Yohannes T. Ghebre is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Cancer & Idiopathic pulmonary fibrosis. The author has an hindex of 8, co-authored 18 publications receiving 438 citations. Previous affiliations of Yohannes T. Ghebre include Houston Methodist Hospital.
Papers
More filters
Journal ArticleDOI
Radiation-Induced Lung Injury: Assessment and Management.
TL;DR: Current research advances include high-precision radiation techniques, an improved understanding of the molecular basis of RILI, the development of small and large animal models, and the identification of candidate drugs for prevention and treatment.
Journal ArticleDOI
Optimal ROS Signaling Is Critical for Nuclear Reprogramming
TL;DR: The data indicate that ROS signaling is activated early with nuclear reprogramming, and optimal levels of ROS signaling are essential to induce pluripotency.
Journal ArticleDOI
Proton Pump Inhibitors Accelerate Endothelial Senescence
Gautham Yepuri,Roman A. Sukhovershin,Timo Z. Nazari-Shafti,Michael Petrascheck,Yohannes T. Ghebre,John P. Cooke +5 more
TL;DR: The data may provide a unifying mechanism for the association of PPI use with increased risk of cardiovascular, renal, and neurological morbidity and mortality and investigate the mechanism involved in PPI-induced vascular dysfunction.
Journal ArticleDOI
Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs.
Yohannes T. Ghebre,Ganesh Raghu +1 more
TL;DR: This study provides an alternative explanation for the beneficial effect of PPIs in IPF including stabilization of lung function, reduction in episodes of acute exacerbation, and enhanced longevity.
Journal ArticleDOI
Vascular Aging: Implications for Cardiovascular Disease and Therapy.
Yohannes T. Ghebre,Eduard Yakubov,Wing Tak Wong,Prasanna Krishnamurthy,Nazish Sayed,Andrew G. Sikora,Mark D. Bonnen +6 more
TL;DR: The impact of advancing age on cardiovascular health is discussed, and the cellular and molecular mechanisms that underlie age-associated vascular changes are highlighted.